You have 9 free searches left this month | for more free features.

insulin resistance

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diabetes, Arteriosclerosis, Peripheral Arterial Occlusive Disease Trial in Vienna (Ilomedin)

Unknown status
  • Diabetes
  • +3 more
  • Vienna, Austria
    Department of vascular and endovascular surgery, Georg Hagmüller
Oct 16, 2018

Diabetes, Type 1, Diabetes, Type 2, Hypersensitivity Trial in Paris (Allergy tests)

Completed
  • Diabetes Mellitus, Type 1
  • +4 more
  • Allergy tests
  • Paris, France
    Cochin Hospital
Mar 16, 2018

Diabetes, Obesity Trial in Boston (Canagliflozin)

Withdrawn
  • Diabetes, Obesity
  • Boston, Massachusetts
    Joslin Diabetes Center
Feb 28, 2017

Diabetes, Type 2, Cardiovascular Diseases, Risk Factors Trial in Worldwide (Placebo, Canagliflozin (JNJ-28431754) 100 mg,

Completed
  • Diabetes Mellitus, Type 2
  • +2 more
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +312 more
Nov 5, 2018

Diabetes, Type 2 Trial in Guangzhou (Insulin LISPRO)

Completed
  • Diabetes Mellitus, Type 2
  • Insulin LISPRO
  • Guangzhou, Guangdong, China
    endocrinology department of the first affiliated hospital of Sun
Apr 17, 2018

Advanced Hematologic Malignancies Trial in Winston-Salem (CPI-613)

Completed
  • Advanced Hematologic Malignancies
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jun 29, 2018

Quinolone Resistance Among ESBL Producing Klebsiella Species

Completed
  • Quinolone Resistance
  • +3 more
    • Pittsburgh, Pennsylvania
      University of Pittsburgh Medical Center
    Jun 13, 2018

    Tissue Collection Framework To Improve Outcomes In Solid Tumours

    Recruiting
    • Solid Tumours
      • London, United Kingdom
        St Bartholomew's Hospital
      Jun 18, 2018

      Skin Tumor Trial in Italy (Pembrolizumab, Cetuximab)

      Unknown status
      • Skin Neoplasm
      • Brescia, BS, Italy
      • +6 more
      Sep 10, 2018

      Diabetes Trial in Albuquerque (Insulin Detemir, Insulin Glargine)

      Completed
      • Diabetes Mellitus
      • Insulin Detemir
      • Insulin Glargine
      • Albuquerque, New Mexico
        University of New Mexico Health Sciences Center
      Feb 22, 2018

      Pre-diabetes Trial in Saint Louis (Control, Xenin-25 without atropine, GIP without atropine)

      Completed
      • Pre-diabetes
      • Saint Louis, Missouri
        Washington University School of Medicine
      May 24, 2018

      Frail Elderly Syndrome Trial in Glasgow (resistance training)

      Unknown status
      • Frail Elderly Syndrome
      • resistance training
      • Glasgow, United Kingdom
        Glasgow Royal Infirmary
      Oct 9, 2018

      Insulin Resistance, Diabetes Trial in Toronto (Intranasal insulin, Intranasal )

      Completed
      • Insulin Resistance, Diabetes
      • Intranasal insulin
      • Intranasal placebo
      • Toronto, Ontario, Canada
        Tornto General Hospital, UHN
      Nov 30, 2015

      Visceral Leishmaniosis, HIV-infection/Aids Trial in Abdurafi, Humera, Gondar (Pentamidine)

      Completed
      • Visceral Leishmaniosis
      • HIV-infection/Aids
      • Abdurafi, Amhara, Ethiopia
      • +2 more
      Oct 5, 2018

      Diabetes, Type 2 Trial in Worldwide (Human Insulin Inhalation Powder, Insulin Glargine)

      Completed
      • Diabetes Mellitus, Type 2
      • Human Insulin Inhalation Powder
      • Insulin Glargine
      • Greenbrae, California
      • +18 more
      Mar 7, 2018

      EPIgenetics and in Vivo Resistance of Chronic Myeloid Leukemia

      Unknown status
      • Chronic Myeloid Leukemia (CML)
      • Chronic Phase
      • Collection of blood and bone marrow
      • Clermont-Ferrand, France
        CHU Clermont-Ferrand
      Oct 8, 2018

      Type 1 Diabetes Trial in Stanford, Aurora, New Haven (Medtronic Hybrid Closed-loop System - Android Platform, Medtronic Hybrid

      Completed
      • Type 1 Diabetes
      • Medtronic Hybrid Closed-loop System - Android Platform
      • Medtronic Hybrid Closed-loop Integrated System
      • Stanford, California
      • +2 more
      Jun 1, 2018

      Osteoarthritis, Knee Trial in Winston-Salem (Aquatic Prehab)

      Completed
      • Osteoarthritis, Knee
      • Aquatic Prehab
      • Winston-Salem, North Carolina
        Clinical Research Unit
      Jun 12, 2019

      Frail Elderly Trial in Hamilton (Higher Intensity Resistance Training, Lower Intensity Resistance Training)

      Completed
      • Frail Elderly
      • Higher Intensity Resistance Training
      • Lower Intensity Resistance Training
      • Hamilton, Ontario, Canada
        McMaster University
      Apr 17, 2018

      HIV Lipodystrophy Trial in Boston (Leptin, Pioglitazone or metformin, Placebo)

      Completed
      • HIV Lipodystrophy
      • Boston, Massachusetts
        Beth Israel Deaconess Medical Center
      Feb 2, 2017

      Risk Factors for Linezolid Resistance in Staphylococcus Aureus

      Completed
      • Linezolid Resistance
      • Staphylococcus Aureus
        • Pittsburgh, Pennsylvania
          University of Pittsburgh Medical Center
        Jun 11, 2018

        Obesity, Overweight With Indications for Weight Loss Trial in Winston-Salem (Pioglitazone, Resistance exercise training to

        Completed
        • Obesity
        • Overweight With Indications for Weight Loss
        • Winston-Salem, North Carolina
          Sticht Center on Aging, Wake Forest University Baptist Medical C
        Jul 30, 2018

        Obesity, Weight Loss Trial in Hellerup (Meal test)

        Completed
        • Obesity
        • Weight Loss
        • Meal test
        • Hellerup, Denmark
          Center for Diabetes Research
        Oct 11, 2018

        Type 1 Diabetes Trial in Charlottesville (Activity on Board, Usual Diabetes Care)

        Completed
        • Type 1 Diabetes Mellitus
        • Activity on Board
        • Usual Diabetes Care
        • Charlottesville, Virginia
          University of Virginia Center for Diabetes Technology
        May 21, 2018

        NSCLC (NSCLC) Trial in Tainan, Taipei (selumetinib)

        Completed
        • Non-small Cell Lung Cancer (NSCLC)
        • Tainan, Taiwan
        • +2 more
        Jul 9, 2018